Tablets of Roche Holding AG's Tarceva cancer drug are arranged for a photograph. Photographer: JB Reed/Bloomberg

Tablets of Roche Holding AG's Tarceva cancer drug are arranged for a photograph. Photographer: JB Reed/Bloomberg

Bloomberg News

Roche Raises Illumina Takeover Bid to $51 a Share

By Thomas Mulier
March 29, 2012

Roche Holding AG (ROG) raised its bid for Illumina Inc. (ILMN) to $51 a share. The company commented in a statement today.

To contact the editor responsible for this story: Thomas Mulier at tmulier@bloomberg.net

Business Exchange: What your peers are reading.

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus